Influenza vaccines: A review and rationale for use in developed and underdeveloped countries

Gregory A. Poland, Scott T. Rottinghaus, Robert M. Jacobson

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

Multiple studies have demonstrated that influenza infection results in considerable morbidity and mortality, as well as other economic consequences, such as school and work absenteeism. Influenza vaccine has been shown to be both cost-effective and cost-saving. Despite this, the influenza vaccine appears to be under-utilized throughout the world, with significant variations both between countries and within countries over time. Data will be discussed that provide a rationale for the use of the influenza vaccine to protect the public health. Recommendations for the use of the influenza vaccine in various countries and guidelines for influenza vaccine use worldwide will be proposed.

Original languageEnglish (US)
Pages (from-to)2216-2220
Number of pages5
JournalVaccine
Volume19
Issue number17-19
DOIs
StatePublished - Mar 21 2001

Keywords

  • Influenza
  • Influenza vaccine
  • Vaccine coverage
  • Vaccine policy

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Influenza vaccines: A review and rationale for use in developed and underdeveloped countries'. Together they form a unique fingerprint.

  • Cite this